
Fate Therapeutics Inc (FATE) is ready for next Episode as it posted an annual sales of 13,630 K
Fate Therapeutics Inc (NASDAQ: FATE) kicked off on Monday, down -4.20%% from the previous trading day, before settling in for the closing price of $1.19.